Technology News and Research

RSS

BioLight forms strategic partnership with Rock-One to expand its presence within China

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced today an agreement to enter into a strategic partnership with Rock-One International Holdings Ltd., a holding company specializing in investment activities, including in the high tech and biomedical industries.

2 Apr 2015

Penn Med's BLINKER Team named one of 16 finalists in NIH 'Follow that Cell Challenge'

James Eberwine, PhD, the Elmer Holmes Bobst Professor of Systems Pharmacology and Experimental Therapeutics, at the Perelman School of Medicine at the University of Pennsylvania, was named one of 16 finalists in the first phase of the Follow that Cell Challenge funded by the National Institutes of Health. The competition was run by crowdsourcing company Innocentive and 687 designated "solvers" entered initially.

2 Apr 2015

Registration opens for inaugural Stanford Medicine X|ED conference

Registration opened today for the inaugural Stanford Medicine X|ED conference, which will explore the role of technology and networked intelligence in shaping the future of medical education.

2 Apr 2015

Novel molecule inhibits cancer-causing transcription factors

A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.

2 Apr 2015

Scientists uncover the genetic root of prostate cancer

Scientists have revealed the root of prostate cancers in individual men, discovering that despite huge genetic variety between tumours they also share common gene faults - insight that could offer new treatment hopes, according to research published in Nature today (Wednesday).

2 Apr 2015

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on the Arcelis technology platform, today announced that the NIH Division of AIDS (DAIDS) has approved $6.6 million in funding for an investigator-initiated Phase 2a adult eradication study of AGS-004, the company’s investigational fully personalized immunotherapy for HIV.

2 Apr 2015

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

McGraw-Hill Education, a leading global provider of content and services for the science, technical, and medical communities, announced the launch of the ObGyn Collection on AccessMedicine, the latest addition to the McGraw-Hill Education suite of comprehensive online resources for medical students, residents, and healthcare professionals.

1 Apr 2015

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

The University of Texas MD Anderson Cancer Center and NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year collaboration to accelerate the development and adoption of a new type of assay based on NanoString's nCounter Analysis System.

From NanoString Technologies 1 Apr 2015

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company has entered into a partnership with American HealthCare Lending to provide funding for patient access to vBloc Therapy, delivered via the Maestro Rechargeable System, for the treatment of obesity.

1 Apr 2015

MHIF investigator performs first atrial fibrillation ablation in U.S. using SMARTTOUCH SF catheter

Dr. Daniel Melby, an investigator at the Minneapolis Heart Institute Foundation, performed the first atrial fibrillation ablation in the U.S. using Biosense Webster's new THERMOCOOL SMARTTOUCH SF contact force sensing catheter as part of an FDA regulated safety trial (SMART-SF).

1 Apr 2015

Hitachi Aloka Medical becomes exclusive global distributor of iVu Imaging’s SOFIA system

Hitachi Aloka Medical, Ltd. (Headquartered in Tokyo, Japan, President: Mr. Minoru Yoshizumi) and iVu Imaging Corporation announced the signing of an agreement making Hitachi Aloka Medical, Ltd. the exclusive global distributor of iVu’s SOFIA system, an automated whole breast ultrasound scanner designed to enable the earlier detection of breast cancer in women with mammographically dense breasts.

1 Apr 2015

Dartmouth-led project aims to address the food-energy-climate nexus

Dartmouth and the University of Maryland have received federal funding to study the environmental and financial benefits of converting methane gas from cow manure into electricity and heat on Vermont and New York dairy farms over the next 60 years.

1 Apr 2015

Study examines efficacy of continuous UV-C robots versus pulsed xenon in preventing infection

The efficacy of continuous UV-C disinfection robots versus pulsed xenon (PU-UX) was highlighted in a recently published study of ultraviolet (UV) light disinfection systems by an influential infection prevention research team, including Curtis Donskey, M.D.

1 Apr 2015

Video gamers perform more accurately than non-gamers on certain visual tasks

Many studies show that video gamers perform better than non-gamers on certain visual tasks, like managing distractors and identifying targets, but a small new Brown University study provides gamers with some cognitive bonus points. The study results suggest that gaming not only improves their visual skill but also may improve their learning ability for those skills.

1 Apr 2015

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year.

31 Mar 2015

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Jacoti bvba announced today the US release of Jacoti ListenApp, the first FDA registered and CE certified medical device hearing aid application for smartphones. Indicated for mild to moderate hearing loss, ListenApp precisely adjusts the sound of an iOS device to the user's audiogram, transforming the device into a sophisticated, flexible and very affordable hearing instrument with extremely high sound quality.

31 Mar 2015

Research reveals stark variation in genetic tests for inherited eye disease in England

New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.

31 Mar 2015

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

Inovalon, a leading technology company providing advanced cloud-based analytics and data-driven intervention platforms to the healthcare industry and the Special Needs Plan (SNP) Alliance, released today the largest analysis ever performed on dual eligible quality outcomes, entitled "An Investigation of Medicare Advantage Dual Eligible Member-Level Performance on the Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Measures."

31 Mar 2015

Roche launches new protein melting application for real-time PCR LightCycler 1536 instrument

Roche announced today the introduction of a new protein melting application for its high-throughput, real-time PCR LightCycler 1536 instrument. The fully automated platform now allows life science researchers to perform thermal shift assays (TSAs) in 1536-well applications quickly and consistently.

From Roche Sequencing and Life Science 31 Mar 2015

Study shows stark variation in genetic testing services for inherited eye conditions in England

New research from The University of Manchester published in the Journal of Community Genetics reveals a stark variation in genetic testing services for inherited eye disease in England.

31 Mar 2015

Technology News and Research

BioLight forms strategic partnership with Rock-One to expand its presence within China

Penn Med's BLINKER Team named one of 16 finalists in NIH 'Follow that Cell Challenge'

Registration opens for inaugural Stanford Medicine X|ED conference

Novel molecule inhibits cancer-causing transcription factors

Scientists uncover the genetic root of prostate cancer

NIH approves $6.6 million in funding for Phase 2a adult eradication study of Argos' AGS-004

McGraw-Hill Education introduces ObGyn Collection on AccessMedicine

MD Anderson, NanoString Technologies collaborate to accelerate development of 'multi-omic' assays

EnteroMedics, American HealthCare Lending partner to support patient access to vBloc Therapy

MHIF investigator performs first atrial fibrillation ablation in U.S. using SMARTTOUCH SF catheter

Hitachi Aloka Medical becomes exclusive global distributor of iVu Imaging’s SOFIA system

Dartmouth-led project aims to address the food-energy-climate nexus

Study examines efficacy of continuous UV-C robots versus pulsed xenon in preventing infection

Video gamers perform more accurately than non-gamers on certain visual tasks

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Jacoti releases first FDA-registered medical device hearing aid application for smartphones

Research reveals stark variation in genetic tests for inherited eye disease in England

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

Roche launches new protein melting application for real-time PCR LightCycler 1536 instrument

Study shows stark variation in genetic testing services for inherited eye conditions in England

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News